CClinicalTrials.gg
CompletedNCT06086756Updated Dec 13, 2023

Virtual Reality Intervention for Speech Anxiety

An interventional study of Exposure intervention plus positive mood induction and Exposure intervention plus negative mood induction in Public Speaking and Speech Anxiety, sponsored by Boston University Charles River Campus. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-13.

Sponsored by Boston University Charles River Campus · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate whether mood state moderates outcome to a brief VR exposure intervention.

Read the detailed description

The goal of this clinical trial is to compare outcomes of VR exposure therapy for college students with public speaking anxiety following a positive or negative mood induction. The overarching aim of the present study is to determine whether mood state prior to engaging in a brief VR exposure therapy session for public speaking anxiety impacts treatment outcomes.

The study involves three phases: (1) initial screening, (2) in-person assessment and brief exposure intervention for a subset of participants with elevated public speaking anxiety, and (3) a one-week follow-up assessment conducted online. Students who choose to participate and screen high on a public speaking anxiety scale will be assigned to a positive or negative mood induction condition prior to undergoing VR based exposure therapy. Public speaking and social anxiety outcomes are measured immediately post-intervention and one week later.

Researchers will compare participants given a positive mood induction to participants given a negative mood induction to see if public speaking anxiety outcomes differ.

02

Conditions studied

  • Public Speaking
  • Speech Anxiety

Browse trials for

03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 48 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Boston University Charles River Campus is the lead sponsor of 154 studies on the registry; 30 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 8 (57%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Self-report of 18 years of age or older
  • Current student at Boston University
  • Ability to read English to provide informed consent
  • Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet).
  • For Phase 2: speech anxiety scale score of ≥ 14 on the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS)

Exclusion criteria

Exclusion Criteria:

  • Previous participation (i.e., no participant may take the survey more than once).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    Positive Mood Induction via positive film clips

    The standardized procedures outlined in our laboratory's previously conducted study (Stathopoulou, Pollack, \& Otto, 2018) will be followed. Participants will be presented with two brief film clips on a computer monitor or TV screen. These film clips were selected to elicit positive affect. As utilized in past lab study procedures, participants will be asked to: "Let yourself experience whatever emotions you have, as fully as you can. Don't try to hold back, or hold in, your feelings" (Stathopoulou, Pollack, \& Otto, 2018). Together, the two film clips will last for approximately 5 minutes.

    Behavioral: Exposure intervention plus positive mood induction

  • Experimental
    Negative Mood Induction via negative film clips

    The standardized procedures outlined in our laboratory's previously conducted study (Stathopoulou, Pollack, \& Otto, 2018) will be followed. Participants will be presented with two brief film clips on a computer monitor or TV screen. These film clips were selected to elicit negative affect. As utilized in past lab study procedures, participants will be asked to: "Let yourself experience whatever emotions you have, as fully as you can. Don't try to hold back, or hold in, your feelings" (Stathopoulou, Pollack, \& Otto, 2018). Together, the two film clips will last for approximately 5 minutes.

    Behavioral: Exposure intervention plus negative mood induction

Interventions

  • BehavioralExposure intervention plus positive mood induction

    Positive mood induction followed by a brief VR exposure session for public speaking anxiety.

  • BehavioralExposure intervention plus negative mood induction

    Negative mood induction followed by a brief VR exposure session for public speaking anxiety.

06

What researchers measure

Primary outcomes

  1. Public Speaking Anxiety

    Assessed using the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS)

    Time frame: Comparison of pre-exposure scores to scores from post-treatment, approximately 2 week post-screen

Secondary outcomes

  1. Valence

    Self-report measure of how participant feels about having to give a speech

    Time frame: Comparison of pre-exposure scores to scores from follow up survey, 1 week post-exposure

  2. Social Phobia

    Assessed using the social phobia inventory (SPIN)

    Time frame: Comparison of pre-exposure scores to scores from follow up survey, 1 week post-exposure

  3. Public Speaking Anxiety

    Assessed using the PRCA-PS

    Time frame: Comparison of pre-exposure scores to scores from follow up survey, 1 week post-exposure

07

Study locations

1 site
  • Center for Anxiety and Related Disorders
    Boston, Massachusetts 02215, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06086756
Lead sponsor
Boston University Charles River Campus
Responsible party
Sponsor
First posted
Oct 17, 2023
Start date
Nov 1, 2023
Primary completion
Dec 5, 2023
Completion
Dec 5, 2023
Last update
Dec 13, 2023

Study contacts

Elias Culver
principal investigator · Boston University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion